Behavior modification and haloperidol in chronic facial pain.
Neuralgiform pain and migrainous pain, both of which are amenable to drug therapy, comprise a relatively small percentage of the group of patients with facial pain who come to the practitioner's office. The largest group of facial pain patients are those with myofascial connective tissue disorders. A second group includes patients with neuropathic pain due to trauma such as oral surgery. A third group is made up of those without any identifiable focus of pain in the extracranial tissue. In these three nonneuralgiform and nonmigrainous groups, it is thought that personality factors affecting psychophysiologic mechanisms are of great importance. These patients are generally difficult to treat. A variety of modalities of therapy, such as behavior modification, hypnosis, and biofeedback, has been reported as helpful in some of these patients. In this report we focus on 12 subjects who failed with all these forms of therapy. We found that they responded to relaxation therapy (after Jacobson) along with haloperidol. We describe further characteristics of these patients and details of our method of treatment.
D002908:Chronic Disease; D005145:Face; D005260:Female; D006220:Haloperidol / Q000627:therapeutic use*; D006801:Humans; D008950:MMPI; D008297:Male; D008875:Middle Aged; D010146:Pain / Q000188:drug therapy / Q000523:psychology; D059408:Pain Management; D012064:Relaxation Therapy
D006220:Haloperidol